Systemic Treatment of Metastatic Conjunctival Melanoma
Open Access
- 1 January 2017
- journal article
- case report
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2017 (1) , 4623964
Abstract
Conjunctival melanoma (CM) is an exceptionally rare tumor, with a propensity for local and distant recurrence, with the lungs, skin, liver, and brain being the most common sites of metastasis. Recent progress in systemic treatments, with checkpoint inhibitors and targeted therapies blocking BRAF and MEK, has redefined the standard of care of advanced unresectable and metastatic melanoma. Although most trials did not include patients with conjunctival melanoma, its close molecular and genetic relationship to cutaneous melanoma might suggest a similar response to these novel agents. The authors describe two uncommon cases of metastatic conjunctival melanomas with distinct genetic profiles and, as such, submitted to different systemic treatments.Keywords
This publication has 17 references indexed in Scilit:
- Vemurafenib-induced progression of breast cancer: a case report and review of the literatureTargeted Oncology, 2015
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trialThe Lancet, 2015
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2015
- Improved Overall Survival in Melanoma with Combined Dabrafenib and TrametinibNew England Journal of Medicine, 2015
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label studyThe Lancet Oncology, 2014
- Conjunctival melanoma with metastasis to the parotid gland in a 10 year-old boy: A case report and literature reviewInternational Journal of Pediatric Otorhinolaryngology Extra, 2013
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialThe Lancet, 2012
- RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsNew England Journal of Medicine, 2012
- Conjunctival MelanomaOphthalmology, 2011
- Malignant Conjunctival Tumors Invading the OrbitOphthalmologica, 2008